NETPD LS1 Creatine in Parkinson''s Disease

NET-PD-LS-1 Creatine in Parkinson Disease-The purpose of this trial is to determine if the nutritional supplement creatine slows the progression of Parkinson Disease over time.

 

You may qualify if:

1) have been diagnosed with Parkinson Disease within the last 5 years

2) are being treated and have been responsive to dopaminergic therapy for at least   

     90 days but no longer than 2 years

3) have not taken over-the-counter creatine within 14 days of starting the study

 

Participation in this study lasts a minimum of 5 years and includes at least 9 follow-up clinic visits and at least 3 telephone calls.

 

For more information about this study contact our clinical research office at 602-406-6259.